The University of Queensland

Constrained cyclic peptides (1996–2000)

Grant type:

Glaxo Wellcome Australia Limited

Researchers:

• 

  Associate Professor Mark Smythe

  Principal Research Fellow - GL
  

  Institute for Molecular Bioscience

Funded by:

Glaxo Wellcome Australia Limited